{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T02:12:42Z","timestamp":1792289562458,"version":"4.4.0"},"update-to":[{"DOI":"10.1002\/14651858.cd012774.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2023,4,25]],"date-time":"2023-04-25T00:00:00Z","timestamp":1682380800000}}],"reference-count":203,"publisher":"Wiley","issue":"4","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd012774.pub3","type":"journal-article","created":{"date-parts":[[2023,4,24]],"date-time":"2023-04-24T20:15:56Z","timestamp":1682367356000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":53,"title":["Fecal transplantation for treatment of inflammatory bowel disease"],"prefix":"10.1002","volume":"2023","author":[{"given":"Aamer","family":"Imdad","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Division of Pediatric Gastroenterology, Hepatology and Nutrition; SUNY Upstate Medical University; Syracuse New York USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasha G","family":"Pandit","sequence":"additional","affiliation":[{"name":"Norton College of Medicine; SUNY Upstate Medical University; Syracuse New York USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muizz","family":"Zaman","sequence":"additional","affiliation":[{"name":"Norton College of Medicine; SUNY Upstate Medical University; Syracuse New York USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan Zev","family":"Minkoff","sequence":"additional","affiliation":[{"name":"Pediatric Gastroenterology, Hepatology and Nutrition; Valley Children's Hospital; Madera CA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily E","family":"Tanner-Smith","sequence":"additional","affiliation":[{"name":"Counseling Psychology and Human Services; University of Oregon; Eugene Oregon USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oscar G","family":"Gomez-Duarte","sequence":"additional","affiliation":[{"name":"Division of Pediatric Infectious Diseases, Department of Pediatrics; University at Buffalo, State University of New York; Buffalo New York USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sari","family":"Acra","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, D. Brent Polk Division of Gastroenterology, Hepatology and Nutrition; Vanderbilt University School of Medicine; Nashville Tennessee USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maribeth R","family":"Nicholson","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, D. Brent Polk Division of Gastroenterology, Hepatology and Nutrition; Vanderbilt University School of Medicine; Nashville Tennessee USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2023,4,25]]},"reference":[{"issue":"13","key":"10.1002\/14651858.CD012774.pub3-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.3390\/jcm10132753","article-title":"Fecal microbial transplantation versus mesalamine enema for treatment of active left-sided ulcerative colitis-results of a randomized controlled trial","volume":"10","author":"B\u0159ezina","year":"2021","journal-title":"Journal of Clinical Medicine"},{"issue":"10","key":"10.1002\/14651858.CD012774.pub3-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.3390\/cells9102283","article-title":"Gut microbiome changes in patients with active left-sided ulcerative colitis after fecal microbiome transplantation and topical 5-aminosalicylic acid therapy","volume":"9","author":"Schierov\u00e1","year":"2020","journal-title":"Cells"},{"issue":"2","key":"10.1002\/14651858.CD012774.pub3-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1001\/jama.2018.20046","article-title":"Effect of fecal microbiota transplantation on 8-week remission in patients with ulcerative colitis: a randomized clinical trial","volume":"321","author":"Costello","year":"2019","journal-title":"JAMA"},{"issue":"1","key":"10.1002\/14651858.CD012774.pub3-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1186\/s12876-021-01856-9","article-title":"Daily, oral FMT for long-term maintenance therapy in ulcerative colitis: results of a single-center, prospective, randomized pilot study","volume":"21","author":"Crothers","year":"2021","journal-title":"BMC Gastroenterology"},{"key":"10.1002\/14651858.CD012774.pub3-BIB0005|cit5","unstructured":"Fecal Microbiota Transplant in the Treatment of Ulcerative Colitis (FMTUC) clinicaltrials.gov\/ct2\/show\/NCT02390726"},{"issue":"1","key":"10.1002\/14651858.CD012774.pub3-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12934-021-01513-6","article-title":"Long-term efficacy and safety of monotherapy with a single fresh fecal microbiota transplant for recurrent active ulcerative colitis: a prospective randomized pilot study","volume":"20","author":"Fang","year":"2021","journal-title":"Microbial Cell Factories"},{"key":"10.1002\/14651858.CD012774.pub3-BIB0007|cit7","unstructured":"Lyophilised oral faecal microbiota transplantation in the management of ulcerative colitis (LOTUS Study) www.anzctr.org.au\/Trial\/Registration\/TrialReview.aspx?id=377325"},{"issue":"2","key":"10.1002\/14651858.CD012774.pub3-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S2468-1253(21)00400-3","article-title":"Lyophilised oral faecal microbiota transplantation for ulcerative colitis (LOTUS): a randomised, double-blind, placebo-controlled trial","volume":"7","author":"Haifer","year":"2022","journal-title":"Lancet Gastroenterology and Hepatology"},{"issue":"5","key":"10.1002\/14651858.CD012774.pub3-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"S","DOI":"10.1016\/S0016-5085(14)60567-9","article-title":"A randomized, placebo controlled trial of fecal microbiota therapy in active ulcerative colitis","volume":"146","author":"Moayyedi","year":"2014","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1002\/14651858.CD012774.pub3-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1053\/j.gastro.2015.04.001","article-title":"Fecal microbiota transplantation induces remission in patients with active ulcerative colitis in a randomized controlled trial","volume":"149","author":"Moayyedi","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD012774.pub3-BIB0011|cit11","unstructured":"Pediatric FEcal Microbiota Transplant for Ulcerative Colitis (PediFETCh) clinicaltrials.gov\/ct2\/show\/NCT02487238"},{"issue":"2","key":"10.1002\/14651858.CD012774.pub3-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1053\/j.gastro.2021.04.067","article-title":"Results of the first pilot randomized controlled trial of fecal microbiota transplant in pediatric ulcerative colitis: lessons, limitations, and future prospects","volume":"161","author":"Pai","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD012774.pub3-BIB0013|cit13","first-page":"S79","article-title":"A randomized, placebo-controlled trial of fecal microbial transplantation for pediatric ulcerative colitis [Pedifetch Trial]","volume":"63","author":"Pai","year":"2016","journal-title":"Journal of Pediatric Gastroenterology and Nutrition"},{"issue":"8","key":"10.1002\/14651858.CD012774.pub3-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"e016698","DOI":"10.1136\/bmjopen-2017-016698","article-title":"Protocol for a randomised, placebo-controlled pilot study for assessing feasibility and efficacy of faecal microbiota transplantation in a paediatric ulcerative colitis population: PediFETCh trial","volume":"7","author":"Pai","year":"2017","journal-title":"BMJ Open"},{"issue":"6","key":"10.1002\/14651858.CD012774.pub3-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"S","DOI":"10.1016\/S0016-5085(19)37996-X","article-title":"Fecal microbiota transplantation: perceptions and experiences in a pediatric ulcerative colitis population (PediFETCH trial)","volume":"156","author":"Popov","year":"2019","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1002\/14651858.CD012774.pub3-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1097\/MPG.0000000000002995","article-title":"Pediatric patient and parent perceptions of fecal microbiota transplantation for the treatment of ulcerative colitis","volume":"73","author":"Popov","year":"2021","journal-title":"Journal of Pediatric Gastroenterology and Nutrition"},{"issue":"10075","key":"10.1002\/14651858.CD012774.pub3-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1016\/S0140-6736(17)30182-4","article-title":"Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: a randomised placebo-controlled trial","volume":"389","author":"Paramsothy","year":"2017","journal-title":"Lancet"},{"issue":"4","key":"10.1002\/14651858.CD012774.pub3-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"S122","DOI":"10.1016\/S0016-5085(16)30517-0","article-title":"Multi donor intense faecal microbiota transplantation is an effective treatment for resistant ulcerative colitis: a randomised placebo-controlled trial","volume":"150","author":"Paramsothy","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD012774.pub3-BIB0019|cit19","first-page":"143","article-title":"Multi donor intense faecal microbiota transplantation is an effective treatment for resistant ulcerative colitis: a randomised placebo controlled trial and microbiota analysis","volume":"31","author":"Paramsothy","year":"2016","journal-title":"Journal of Gastroenterology and Hepatology (Australia)"},{"issue":"8","key":"10.1002\/14651858.CD012774.pub3-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1038\/ismej.2017.44","article-title":"Microbial shifts and signatures of long-term remission in ulcerative colitis after faecal microbiota transplantation","volume":"11","author":"Fuentes","year":"2017","journal-title":"ISME Journal"},{"issue":"1","key":"10.1002\/14651858.CD012774.pub3-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1053\/j.gastro.2015.03.045","article-title":"Findings from a randomized controlled trial of fecal transplantation for patients with ulcerative colitis","volume":"149","author":"Rossen","year":"2015","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1002\/14651858.CD012774.pub3-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"737","DOI":"10.3390\/microorganisms10040737","article-title":"Fecal filobasidium is associated with clinical remission and endoscopic response following fecal microbiota transplantation in mild-to-moderate ulcerative colitis","volume":"10","author":"Thiel","year":"2022","journal-title":"Microorganisms"},{"key":"10.1002\/14651858.CD012774.pub3-BIB0023|cit23","unstructured":"Fecal transplantation using a diet for donor and recipient in refractory colitis clinicaltrials.gov\/ct2\/show\/NCT02734589"},{"issue":"3","key":"10.1002\/14651858.CD012774.pub3-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1093\/ecco-jcc\/jjab165","article-title":"Use of faecal transplantation with a novel diet for mild to moderate active ulcerative colitis: the craft uc randomised controlled trial","volume":"16","author":"Sarbagili Shabat","year":"2022","journal-title":"Journal of Crohn's and Colitis"},{"issue":"1","key":"10.1002\/14651858.CD012774.pub3-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s40168-020-0792-5","article-title":"Fecal microbiota transplantation to maintain remission in Crohn's disease: a pilot randomized controlled study","volume":"8","author":"Sokol","year":"2020","journal-title":"Microbiome"},{"key":"10.1002\/14651858.CD012774.pub3-BIB0026|cit26","first-page":"A74","article-title":"Maintenance with faecal microbiota transplantation enhances deep remission in patients with ulcerative colitis in clinical remission","volume":"67","author":"Midha","year":"2018","journal-title":"Gut"},{"issue":"10","key":"10.1002\/14651858.CD012774.pub3-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1093\/ecco-jcc\/jjz060","article-title":"Role of faecal microbiota transplantation for maintenance of remission in patients with ulcerative colitis: a pilot study","volume":"13","author":"Sood","year":"2019","journal-title":"Journal of Crohn's and Colitis"},{"issue":"9","key":"10.1002\/14651858.CD012774.pub3-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1007\/s10620-019-05596-5","article-title":"Capsule-delivered fecal microbiota transplant is safe and well tolerated in patients with ulcerative colitis","volume":"64","author":"Adler","year":"2019","journal-title":"Digestive Diseases and Sciences"},{"issue":"4","key":"10.1002\/14651858.CD012774.pub3-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"S742","DOI":"10.1016\/S0016-5085(16)32519-7","article-title":"Irregular bowel movements following fecal microbiota transplantation (FMT) are associated with pre-existing irritable bowel syndrome but not FMT-related factors","volume":"150","author":"Allegretti","year":"2016","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1002\/14651858.CD012774.pub3-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/00004836-200307000-00012","article-title":"Treatment of ulcerative colitis using fecal bacteriotherapy","volume":"37","author":"Borody","year":"2003","journal-title":"Journal of Clinical Gastroenterology"},{"key":"10.1002\/14651858.CD012774.pub3-BIB0031|cit31","first-page":"A76","article-title":"Faecal microbiota transplantation by capsules for active uncreative colitis: a randomised trial","volume":"67","author":"Chen","year":"2018","journal-title":"Gut"},{"issue":"11","key":"10.1002\/14651858.CD012774.pub3-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1111\/1751-2980.12938","article-title":"Efficacy and safety of fecal microbiota transplantation by washed preparation in patients with moderate to severely active ulcerative colitis","volume":"21","author":"Chen","year":"2020","journal-title":"Journal of Digestive Diseases"},{"issue":"4","key":"10.1002\/14651858.CD012774.pub3-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.cgh.2016.11.028","article-title":"Fecal microbiota transplantation for recurrent clostridium difficile infection in patients with inflammatory bowel disease: a single-center experience","volume":"15","author":"Chin","year":"2017","journal-title":"Clinical Gastroenterology and Hepatology"},{"issue":"7","key":"10.1002\/14651858.CD012774.pub3-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1007\/s40264-019-00809-2","article-title":"Long-term safety and efficacy of fecal microbiota transplant in active ulcerative colitis","volume":"42","author":"Ding","year":"2019","journal-title":"Drug Safety"},{"issue":"6","key":"10.1002\/14651858.CD012774.pub3-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"S","DOI":"10.1016\/S0016-5085(20)30716-2","article-title":"Antibiotic pretreatment prior to fecal microbiota transplantation increases rates of remission in patients with mild to moderate ulcerative colitis: results from a pilot randomized clinical trial","volume":"158","author":"El-Nachef","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD012774.pub3-BIB0036|cit36","first-page":"199","article-title":"The preliminary investigation of faecal microbiota transplantation for paediatric recurrent chronic bowel diseases and literature review","volume":"22","author":"Fang","year":"2017","journal-title":"Hong Kong Journal of Paediatrics"},{"issue":"10","key":"10.1002\/14651858.CD012774.pub3-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1097\/MIB.0000000000000908","article-title":"Fecal microbiota transplantation is safe and efficacious for recurrent or refractory clostridium difficile infection in patients with inflammatory bowel disease","volume":"22","author":"Fischer","year":"2016","journal-title":"Inflammatory Bowel Diseases"},{"issue":"2","key":"10.1002\/14651858.CD012774.pub3-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1053\/gast.2000.9370","article-title":"Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial","volume":"119","author":"Gionchetti","year":"2000","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1002\/14651858.CD012774.pub3-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1111\/apt.13326","article-title":"Microbiome changes associated with sustained eradication of Clostridium difficile after single faecal microbiota transplantation in children with and without inflammatory bowel disease","volume":"42","author":"Hourigan","year":"2015","journal-title":"Alimentary Pharmacology and Therapeutics"},{"issue":"1","key":"10.1002\/14651858.CD012774.pub3-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1097\/MIB.0000000000000975","article-title":"Changes in intestinal microbiota following combination therapy with fecal microbial transplantation and antibiotics for ulcerative colitis","volume":"23","author":"Ishikawa","year":"2017","journal-title":"Inflammatory Bowel Diseases"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD012774.pub3-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"S472","DOI":"10.1093\/ecco-jcc\/jjx002.887","article-title":"Combination therapy of fresh fecal microbial transplantation and antibiotics for ulcerative colitis","volume":"11","author":"Ishikawa","year":"2017","journal-title":"Journal of Crohn's and Colitis"},{"key":"10.1002\/14651858.CD012774.pub3-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.14309\/01.ajg.0000578280.72223.d3","article-title":"Combination therapy of fresh fecal microbial transplantation and triple-antibiotic therapy for ulcerative colitis","volume":"114","author":"Ishikawa","year":"2019","journal-title":"American Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD012774.pub3-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"779205","DOI":"10.3389\/fmed.2022.779205","article-title":"A randomized placebo-controlled trial of combination therapy with post-triple-antibiotic-therapy fecal microbiota transplantation and alginate for ulcerative colitis: protocol","volume":"9","author":"Ishikawa","year":"2022","journal-title":"Frontiers in Medicine (Lausanne)"},{"key":"10.1002\/14651858.CD012774.pub3-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/5584_2017_123","article-title":"A two-week fecal microbiota transplantation course in pediatric patients with inflammatory bowel disease","volume":"1047","author":"Karolewska-Bochenek","year":"2018","journal-title":"Advances in Experimental Medicine and Biology"},{"issue":"7","key":"10.1002\/14651858.CD012774.pub3-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"S","DOI":"10.1016\/S0016-5085(22)64055-1","article-title":"Combination of fecal microbiota transplantation and anti-inflammatory diet induces clinical and deep remission in patients with mild-moderate ulcerative colitis","volume":"162","author":"Kedia","year":"2022","journal-title":"Gastroenterology"},{"issue":"12","key":"10.1002\/14651858.CD012774.pub3-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1136\/gutjnl-2022-327811","article-title":"Faecal microbiota transplantation with anti-inflammatory diet (FMT-AID) followed by anti-inflammatory diet alone is effective in inducing and maintaining remission over 1 year in mild to moderate ulcerative colitis: a randomised controlled trial","volume":"71","author":"Kedia","year":"2022","journal-title":"Gut"},{"issue":"1","key":"10.1002\/14651858.CD012774.pub3-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/apt.14387","article-title":"The taxonomic composition of the donor intestinal microbiota is a major factor influencing the efficacy of faecal microbiota transplantation in therapy refractory ulcerative colitis","volume":"47","author":"Kump","year":"2018","journal-title":"Alimentary Pharmacology and Therapeutics"},{"key":"10.1002\/14651858.CD012774.pub3-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"A162","DOI":"10.1136\/gutjnl-2013-304907.367","article-title":"A prospective controlled pilot study of fecal microbiota transplantation for chronic refractory pouchitis","volume":"62","author":"Landy","year":"2013","journal-title":"Gut"},{"issue":"8","key":"10.1002\/14651858.CD012774.pub3-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"e00224","DOI":"10.14309\/ctg.0000000000000224","article-title":"Fecal microbiota transplantation for ulcerative colitis: the optimum timing and gut microbiota as predictors for long-term clinical outcomes","volume":"11","author":"Li","year":"2020","journal-title":"Clinical and Translational Gastroenterology"},{"issue":"8","key":"10.1002\/14651858.CD012774.pub3-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1097\/MEG.0000000000001725","article-title":"Enhancing patient adherence to fecal microbiota transplantation maintains the long-term clinical effects in ulcerative colitis","volume":"32","author":"Li","year":"2020","journal-title":"European Journal of Gastroenterology and Hepatology"},{"key":"10.1002\/14651858.CD012774.pub3-BIB0051|cit51","unstructured":"Standardized fecal microbiota transplantation for ulcerative colitis www.clinicaltrials.gov\/ct2\/show\/NCT01790061"},{"issue":"6","key":"10.1002\/14651858.CD012774.pub3-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"S","DOI":"10.1016\/S0016-5085(20)31862-X","article-title":"A rationally selected, orally administered, live biotherapeutic confortium of commensial bacteria for the treatment of ulcerative colitis","volume":"158","author":"Ma","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD012774.pub3-BIB0053|cit53","first-page":"A74","article-title":"Efficacy of faecal microbiota therapy in patients with steroid dependent active ulcerative colitis","volume":"67","author":"Mahajan","year":"2018","journal-title":"Gut"},{"issue":"5","key":"10.1002\/14651858.CD012774.pub3-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1007\/s00384-015-2396-2","article-title":"Fecal transplant is as effective and safe in immunocompromised as non-immunocompromised patients for Clostridium difficile","volume":"31","author":"Mandalia","year":"2016","journal-title":"International Journal of Colorectal Disease"},{"key":"10.1002\/14651858.CD012774.pub3-BIB0055|cit55","doi-asserted-by":"publisher","DOI":"10.1097\/MPG.0000000000001772","article-title":"Fecal microbial transplant in children with ulcerative colitis: a randomized, double-blinded, placebo-controlled pilot study: retracted","volume":"10.1097\/MPG.000","author":"Michail","year":"2018","journal-title":"Journal of Pediatric Gastroenterology and Nutrition"},{"key":"10.1002\/14651858.CD012774.pub3-BIB0056|cit56","unstructured":"The effect of therapeutic fecal transplant on the gut microbiome in children with ulcerative colitis (FMT_UC) www.clinicaltrials.gov\/ct2\/show\/NCT02291523"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD012774.pub3-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1097\/01.MIB.0000480184.07677.0e","article-title":"Comparing fecal microbial transplant outcomes in patients with recurrent Clostridium difficile or ulcerative colitis","volume":"22","author":"Mintz","year":"2016","journal-title":"Inflammatory Bowel Diseases"},{"key":"10.1002\/14651858.CD012774.pub3-BIB0058|cit58","unstructured":"Fecal microbiota transplantation in the treatment of inflammatory bowel disease (FMT-IBD) clinicaltrials.gov\/ct2\/show\/NCT04436874"},{"key":"10.1002\/14651858.CD012774.pub3-BIB0059|cit59","unstructured":"Oral fecal microbiota transplantation in pediatric ulcerative colitis (T-FORE) clinicaltrials.gov\/ct2\/show\/NCT05202990"},{"issue":"6","key":"10.1002\/14651858.CD012774.pub3-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.3390\/jcm9061650","article-title":"Matching between donors and ulcerative colitis patients is important for long-term maintenance after fecal microbiota transplantation","volume":"9","author":"Okahara","year":"2020","journal-title":"Journal of Clinical Medicine"},{"issue":"3","key":"10.1002\/14651858.CD012774.pub3-BIB0061|cit61","first-page":"87","article-title":"Clinical response and changes in the fecal microbiota and metabolite levels after fecal microbiota transplantation in patients with inflammatory bowel disease and recurrent Clostridioides difficile infection","volume":"7","author":"Osaki","year":"2021","journal-title":"Fujita Medical Journal"},{"issue":"11","key":"10.1002\/14651858.CD012774.pub3-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"e030659","DOI":"10.1136\/bmjopen-2019-030659","article-title":"STOP-Colitis pilot trial protocol: a prospective, open-label, randomised pilot study to assess two possible routes of faecal microbiota transplant delivery in patients with ulcerative colitis","volume":"9","author":"Quraishi","year":"2019","journal-title":"BMJ Open"},{"key":"10.1002\/14651858.CD012774.pub3-BIB0063|cit63","first-page":"A28","article-title":"Novel interactions between bacterial strains and mucosal immune profiles after FMT for UC: STOP-colitis results","volume":"71","author":"Quraishi","year":"2022","journal-title":"Gut"},{"issue":"Suppl 8","key":"10.1002\/14651858.CD012774.pub3-BIB0064|cit64","first-page":"A69","article-title":"Frozen donor stool for fecal microbiota transplantation is as effective as fresh stool in inducing response and remission in active ulcerative colitis","volume":"6","author":"Rainer","year":"2018","journal-title":"United European Gastroenterology Journal"},{"issue":"3","key":"10.1002\/14651858.CD012774.pub3-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1053\/j.gastro.2021.12.137","article-title":"Randomized, double-blind, placebo (pbo)-controlled, single- and multiple-dose phase 1 study of VE202, a defined bacterial consortium for treatment of IBD: safety and colonization dynamics of a novel live biotherapeutic product (LBP) in healthy adults","volume":"162","author":"Silber","year":"2022","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD012774.pub3-BIB0066|cit66","unstructured":"Optimal fecal microbiota transplant dosing for mild to moderate ulcerative colitis clinicaltrials.gov\/ct2\/show\/NCT03006809"},{"issue":"1","key":"10.1002\/14651858.CD012774.pub3-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"5517","DOI":"10.1038\/s41598-022-09307-5","article-title":"Strain-resolved analysis in a randomized trial of antibiotic pretreatment and maintenance dose delivery mode with fecal microbiota transplant for ulcerative colitis","volume":"12","author":"Smith","year":"2022","journal-title":"Scientific Reports"},{"issue":"1","key":"10.1002\/14651858.CD012774.pub3-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"78","DOI":"10.5217\/ir.2018.00089","article-title":"Efficacy of fecal microbiota therapy in steroid dependent ulcerative colitis: a real world intention-to-treat analysis","volume":"17","author":"Sood","year":"2019","journal-title":"Intestinal Research"},{"issue":"11","key":"10.1002\/14651858.CD012774.pub3-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1093\/ecco-jcc\/jjz073","article-title":"Long-term multidonor faecal microbiota transfer by oral capsules for active ulcerative colitis","volume":"13","author":"Steube","year":"2019","journal-title":"Journal of Crohn's and Colitis"},{"key":"10.1002\/14651858.CD012774.pub3-BIB0070|cit70","unstructured":"Fecal microbiota transplantation for ulcerative colitis (FMTFUC) clinicaltrials.gov\/ct2\/show\/NCT03016780"},{"issue":"1","key":"10.1002\/14651858.CD012774.pub3-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s12876-019-1010-4","article-title":"Fecal microbiota transplantation for ulcerative colitis: a prospective clinical study","volume":"19","author":"Tian","year":"2019","journal-title":"BMC Gastroenterology"},{"key":"10.1002\/14651858.CD012774.pub3-BIB0072|cit72","unstructured":"A trial of a combination therapy of fecal microbial transplantation and antibiotics for inflammatory bowel disease center6.umin.ac.jp\/cgi-open-bin\/ctr_e\/ctr_his_list.cgi?recptno=R000029717"},{"key":"10.1002\/14651858.CD012774.pub3-BIB0073|cit73","unstructured":"Research on the efficacy of fecal microbiota transplantation and microbiota in Japanese children with ulcerative colitis center6.umin.ac.jp\/cgi-open-bin\/ctr_e\/ctr_view.cgi?recptno=R000030424"},{"key":"10.1002\/14651858.CD012774.pub3-BIB0074|cit74","unstructured":"Single center randomized study: alginate combined fecal microbiota transplantation for ulcerative colitis center6.umin.ac.jp\/cgi-open-bin\/ctr_e\/ctr_view.cgi?recptno=R000047906"},{"issue":"1","key":"10.1002\/14651858.CD012774.pub3-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1186\/s12866-016-0869-2","article-title":"Pectin enhances the effect of fecal microbiota transplantation in ulcerative colitis by delaying the loss of diversity of gut flora","volume":"16","author":"Wei","year":"2016","journal-title":"BMC Microbiology"},{"key":"10.1002\/14651858.CD012774.pub3-BIB0076|cit76","unstructured":"Standardized fecal microbiota transplantation for Crohn's disease clinicaltrials.gov\/ct2\/show\/NCT01793831"},{"issue":"3","key":"10.1002\/14651858.CD012774.pub3-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1111\/1751-7915.13536","article-title":"Efficacy of faecal microbiota transplantation in Crohn's disease: a new target treatment?","volume":"13","author":"Xiang","year":"2020","journal-title":"Microbial Biotechnology"},{"issue":"1","key":"10.1002\/14651858.CD012774.pub3-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1007\/s10620-019-05751-y","article-title":"Fecal microbiota transplant via endoscopic delivering through small intestine and colon: no difference for Crohn's disease","volume":"65","author":"Yang","year":"2020","journal-title":"Digestive Diseases and Sciences"},{"issue":"Suppl 5","key":"10.1002\/14651858.CD012774.pub3-BIB0079|cit79","first-page":"A112","article-title":"Fecal microbiota transplant for Crohn's disease: a prospective, randomized study in Chinese population","volume":"5","author":"Yang","year":"2017","journal-title":"United European Gastroenterology Journal"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD012774.pub3-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"i003","DOI":"10.1093\/ecco-jcc\/jjab232.002","article-title":"Standardized faecal microbiota transplantation with microbiome-guided donor selection in active UC patients: a randomized, placebo-controlled intervention study","volume":"16","author":"Caenepeel","year":"2022","journal-title":"Journal of Crohn's and Colitis"},{"issue":"7","key":"10.1002\/14651858.CD012774.pub3-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"S","DOI":"10.1016\/S0016-5085(22)60239-7","article-title":"Standardized fecal microbiota transplantation through microbiome-guided donor selection in active ulcerative colitis patients: a randomized, placebo-controlled intervention study","volume":"162","author":"Deleu","year":"2022","journal-title":"Gastroenterology"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD012774.pub3-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"i612","DOI":"10.1093\/ecco-jcc\/jjab232.838","article-title":"Faecal microbiota transplant in ulcerative colitis (FMTUC) \u2013 a randomised clinical trial feasibility study","volume":"16","author":"Jitsumura","year":"2022","journal-title":"Journal of Crohn's and Colitis"},{"issue":"10","key":"10.1002\/14651858.CD012774.pub3-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"e021987","DOI":"10.1136\/bmjopen-2018-021987","article-title":"Protocol for faecal microbiota transplantation in ulcerative colitis (FMTUC): a randomised feasibility study","volume":"8","author":"Jitsumura","year":"2018","journal-title":"BMJ Open"},{"key":"10.1002\/14651858.CD012774.pub3-BIB0084|cit84","unstructured":"Fecal microbial transplant in pediatric Crohn's disease (FMTCD) clinicaltrials.gov\/ct2\/show\/NCT02272868"},{"issue":"1","key":"10.1002\/14651858.CD012774.pub3-BIB0085|cit85","first-page":"68","article-title":"Effect of fecal microbiota transplantation on gastrointestinal function and intestinal flora in patients with ulcerative colitis","volume":"27","author":"Zhang","year":"2019","journal-title":"Shijie Huaren Xiaohua Zazhi"},{"key":"10.1002\/14651858.CD012774.pub3-BIB0086|cit86","unstructured":"Stool transplant for treatment of colitis and Crohns disease trialsearch.who.int\/Trial2.aspx?TrialID=CTRI\/2021\/03\/032131"},{"key":"10.1002\/14651858.CD012774.pub3-BIB0087|cit87","unstructured":"Fecal microbiota transplantation in Crohn's disease as relay after anti-TNF withdrawal www.clinicaltrialsregister.eu\/ctr-search\/trial\/2019-003816-29\/FR"},{"key":"10.1002\/14651858.CD012774.pub3-BIB0088|cit88","unstructured":"Fecal microbiota transplantation in patients with ulcerative colitis clinicaltrials.gov\/ct2\/show\/NCT01961492"},{"key":"10.1002\/14651858.CD012774.pub3-BIB0089|cit89","unstructured":"Standardized fecal microbiota transplantation for inflammatory bowel disease (SFMT-IBD) clinicaltrials.gov\/ct2\/show\/NCT02335281"},{"key":"10.1002\/14651858.CD012774.pub3-BIB0090|cit90","unstructured":"Fecal microbiota transplantation for ulcerative colitis through colonic transendoscopic enteral tubing clinicaltrials.gov\/ct2\/show\/NCT02998112"},{"key":"10.1002\/14651858.CD012774.pub3-BIB0091|cit91","unstructured":"Fecal transplant for Crohn's disease clinicaltrials.gov\/ct2\/show\/NCT03078803"},{"key":"10.1002\/14651858.CD012774.pub3-BIB0092|cit92","unstructured":"Restoration of the microbiome through superdonor selection (RESTORE-UC) clinicaltrials.gov\/ct2\/show\/NCT03110289"},{"key":"10.1002\/14651858.CD012774.pub3-BIB0093|cit93","unstructured":"Fecal microbiota transplantation in ulcerative colitis clinicaltrials.gov\/ct2\/show\/NCT03273465"},{"key":"10.1002\/14651858.CD012774.pub3-BIB0094|cit94","unstructured":"Impact of fecal microbiota transplantation in ulcerative colitis (REBALANCE-UC) clinicaltrials.gov\/ct2\/show\/NCT03483246"},{"key":"10.1002\/14651858.CD012774.pub3-BIB0095|cit95","unstructured":"Fecal transplantation in ulcerative colitis (FMT-CU) clinicaltrials.gov\/ct2\/show\/NCT03561532"},{"key":"10.1002\/14651858.CD012774.pub3-BIB0096|cit96","unstructured":"Capsulized fecal microbiota transplantation in pediatric ulcerative colitis patients (FMT UC) clinicaltrials.gov\/ct2\/show\/NCT03582969"},{"key":"10.1002\/14651858.CD012774.pub3-BIB0097|cit97","unstructured":"Fecal microbiota therapy vs 5-aminosalicylates for induction of remission in newly diagnosed mild-moderately active UC clinicaltrials.gov\/ct2\/show\/NCT03716388"},{"key":"10.1002\/14651858.CD012774.pub3-BIB0098|cit98","unstructured":"Fecal microbiota transplantation for ulcerative colitis clinicaltrials.gov\/ct2\/show\/NCT03804931"},{"key":"10.1002\/14651858.CD012774.pub3-BIB0099|cit99","unstructured":"Examining the efficacy of fecal microbiota transplantation (FMT) and dietary fiber in patients with ulcerative colitis (MINDFUL) clinicaltrials.gov\/ct2\/show\/NCT03998488"},{"key":"10.1002\/14651858.CD012774.pub3-BIB0100|cit100","unstructured":"Safety and efficacy of heterologous FMT by SQIMC-md capsule in mild-moderate ulcerative colitis patients (SQIMC-md) clinicaltrials.gov\/ct2\/show\/NCT04034758"},{"key":"10.1002\/14651858.CD012774.pub3-BIB0101|cit101","unstructured":"NCT04202211 clinicaltrials.gov\/ct2\/show\/NCT04202211"},{"key":"10.1002\/14651858.CD012774.pub3-BIB0102|cit102","unstructured":"Fecal microbial transplantation and vedolizumab treatment of Crohn's disease clinicaltrials.gov\/ct2\/show\/NCT04328922"},{"key":"10.1002\/14651858.CD012774.pub3-BIB0103|cit103","unstructured":"Evaluation of the safety and efficacy of lyophilized fecal microbiota transplantation administered orally for prevention of relapse or intestinal inflammation in adults with ulcerative colitis clinicaltrials.gov\/ct2\/show\/NCT04373473"},{"key":"10.1002\/14651858.CD012774.pub3-BIB0104|cit104","unstructured":"Fecal microbiota transplantation as a treatment for ulcerative colitis clinicaltrials.gov\/ct2\/show\/NCT04434872"},{"key":"10.1002\/14651858.CD012774.pub3-BIB0105|cit105","unstructured":"The effect of intestinal microbiota transplantation for inflammatory bowel diseases (IBD) clinicaltrials.gov\/ct2\/show\/NCT03426683"},{"key":"10.1002\/14651858.CD012774.pub3-BIB0106|cit106","unstructured":"A multicenter clinical trial: efficacy, safety of fecal microbiota transplantation for inflammatory bowel disease clinicaltrials.gov\/ct2\/show\/NCT04521205"},{"key":"10.1002\/14651858.CD012774.pub3-BIB0107|cit107","unstructured":"Fecal microbiota transplantation in postoperative Crohn's disease clinicaltrials.gov\/ct2\/show\/NCT04637438"},{"key":"10.1002\/14651858.CD012774.pub3-BIB0108|cit108","unstructured":"Safety and efficacy of faecal microbiota transplantation in treatment-na\u00efve patients with newly diagnosed chronic inflammatory diseases (FRONT) clinicaltrials.gov\/ct2\/show\/NCT04924270"},{"key":"10.1002\/14651858.CD012774.pub3-BIB0109|cit109","unstructured":"The MIRO II study: microbial restoration in inflammatory bowel diseases (MIRO II) clinicaltrials.gov\/ct2\/show\/NCT04970446"},{"key":"10.1002\/14651858.CD012774.pub3-BIB0110|cit110","unstructured":"Fecal microbiota transplantation in Crohn's disease as relay after anti-TNF withdrawal (MIRACLE) clinicaltrials.gov\/ct2\/show\/NCT04997733"},{"key":"10.1002\/14651858.CD012774.pub3-BIB0111|cit111","unstructured":"Clinical study on the fecal microbiota transplantation in the treatment of ulcerative colitis with depression clinicaltrials.gov\/ct2\/show\/NCT05030064"},{"key":"10.1002\/14651858.CD012774.pub3-BIB0112|cit112","unstructured":"Effectiveness of fecal microbiota transplantation as add-on therapy in mild-to-moderate ulcerative colitis clinicaltrials.gov\/ct2\/show\/NCT05538026"},{"issue":"11","key":"10.1002\/14651858.CD012774.pub3-BIB0113|cit113","doi-asserted-by":"crossref","first-page":"e030120","DOI":"10.1136\/bmjopen-2019-030120","article-title":"Protocol for a double-blind, randomised, placebo-controlled pilot study for assessing the feasibility and efficacy of faecal microbiota transplant in a paediatric Crohn's disease population: PediCRaFT Trial","volume":"9","author":"Pai","year":"2019","journal-title":"BMJ Open"},{"issue":"1","key":"10.1002\/14651858.CD012774.pub3-BIB0114|cit114","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1186\/s13063-022-06095-1","article-title":"Transfer of FRozen Encapsulated multi-donor Stool filtrate for active ulcerative Colitis (FRESCO): study protocol for a prospective, multicenter, double-blind, randomized, controlled trial","volume":"23","author":"Stallmach","year":"2022","journal-title":"Trials"},{"key":"10.1002\/14651858.CD012774.pub3-BIB0115|cit115","unstructured":"Multicenter randomized controlled trial to study the efficacy of multidonor fecal microbiota transplantation for Crohn's disease center6.umin.ac.jp\/cgi-open-bin\/ctr_e\/ctr_view.cgi?recptno=R000037777"},{"issue":"21","key":"10.1002\/14651858.CD012774.pub3-BIB0116|cit116","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1056\/NEJMra0804647","article-title":"Inflammatory bowel disease","volume":"361","author":"Abraham","year":"2009","journal-title":"New England Journal of Medicine"},{"issue":"7","key":"10.1002\/14651858.CD012774.pub3-BIB0117|cit117","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1097\/MCG.0b013e318247c32f","article-title":"Natural history of pediatric-onset inflammatory bowel disease: a systematic review","volume":"46","author":"Abraham","year":"2012","journal-title":"Journal of Clinical Gastroenterology"},{"issue":"3","key":"10.1002\/14651858.CD012774.pub3-BIB0118|cit118","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/j.1751-2980.2010.00429.x","article-title":"Inflammatory bowel disease in the Asia-Pacific area: a comparison with developed countries and regional differences","volume":"11","author":"Ahuja","year":"2010","journal-title":"Journal of Digestive Diseases"},{"issue":"1","key":"10.1002\/14651858.CD012774.pub3-BIB0119|cit119","doi-asserted-by":"crossref","first-page":"ofv004","DOI":"10.1093\/ofid\/ofv004","article-title":"Weight gain after fecal microbiota transplantation","volume":"2","author":"Alang","year":"2015","journal-title":"Open Forum Infectious Diseases"},{"issue":"4","key":"10.1002\/14651858.CD012774.pub3-BIB0120|cit120","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/nrgastro.2015.34","article-title":"Epidemiology and risk factors for IBD","volume":"12","author":"Ananthakrishnan","year":"2015","journal-title":"Nature Reviews Gastroenterology and Hepatology"},{"issue":"6","key":"10.1002\/14651858.CD012774.pub3-BIB0121|cit121","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/j.1365-2036.2012.05220.x","article-title":"Systematic review: faecal microbiota transplantation in the management of inflammatory bowel disease","volume":"36","author":"Anderson","year":"2012","journal-title":"Alimentary Pharmacology and Therapeutics"},{"issue":"4","key":"10.1002\/14651858.CD012774.pub3-BIB0122|cit122","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.crohns.2011.12.016","article-title":"Results of the 2nd scientific workshop of the ECCO (IV): therapeutic strategies to enhance intestinal healing in inflammatory bowel disease","volume":"6","author":"Armuzzi","year":"2012","journal-title":"Journal of Crohn's and Colitis"},{"issue":"7","key":"10.1002\/14651858.CD012774.pub3-BIB0123|cit123","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1097\/MIB.0000000000000776","article-title":"Mucosa-associated ileal microbiota in new-onset pediatric Crohn's disease","volume":"22","author":"Assa","year":"2016","journal-title":"Inflammatory Bowel Diseases"},{"issue":"6","key":"10.1002\/14651858.CD012774.pub3-BIB0124|cit124","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.amjmed.2014.02.017","article-title":"Fecal microbiota transplantation in the treatment of Clostridium difficile infections","volume":"127","author":"Austin","year":"2014","journal-title":"American Journal of Medicine"},{"key":"10.1002\/14651858.CD012774.pub3-BIB0125|cit125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.21767\/2575-7733.1000002","article-title":"Assessment of mucosal healing in inflammatory bowel disease","volume":"1","author":"Auzoux","year":"2017","journal-title":"Journal of Clinical Gastroenterology and Hepatology"},{"issue":"3","key":"10.1002\/14651858.CD012774.pub3-BIB0126|cit126","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1093\/ecco-jcc\/jjac150","article-title":"Most placebo-controlled trials in inflammatory bowel disease were underpowered because of overestimated drug efficacy rates: results from a systematic review of induction studies","volume":"17","author":"Bahnam","year":"2023","journal-title":"Journal of Crohn's and Colitis"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD012774.pub3-BIB0127|cit127","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1159\/000437104","article-title":"Targeting the microbiome in inflammatory bowel disease: critical evaluation of current concepts and moving to new horizons","volume":"33","author":"Bejaoui","year":"2015","journal-title":"Digestive Diseases"},{"issue":"6275","key":"10.1002\/14651858.CD012774.pub3-BIB0128|cit128","doi-asserted-by":"crossref","first-page":"10.1126\/science","DOI":"10.1126\/science.aad3311","article-title":"Gut bacteria that prevent growth impairments transmitted by microbiota from malnourished children","volume":"351","author":"Blanton","year":"2016","journal-title":"Science"},{"issue":"9","key":"10.1002\/14651858.CD012774.pub3-BIB0129|cit129","doi-asserted-by":"crossref","first-page":"e0238910","DOI":"10.1371\/journal.pone.0238910","article-title":"Fecal microbiota transplantation in inflammatory bowel disease patients: a systematic review and meta-analysis","volume":"15","author":"Caldeira","year":"2020","journal-title":"PLOS One"},{"issue":"9","key":"10.1002\/14651858.CD012774.pub3-BIB0130|cit130","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1111\/apt.13144","article-title":"Randomised clinical trial: faecal microbiota transplantation by colonoscopy vs. vancomycin for the treatment of recurrent Clostridium difficile infection","volume":"41","author":"Cammarota","year":"2015","journal-title":"Alimentary Pharmacology and Therapeutics"},{"issue":"4","key":"10.1002\/14651858.CD012774.pub3-BIB0131|cit131","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1136\/gutjnl-2016-313017","article-title":"European consensus conference on faecal microbiota transplantation in clinical practice","volume":"66","author":"Cammarota","year":"2017","journal-title":"Gut"},{"issue":"9","key":"10.1002\/14651858.CD012774.pub3-BIB0132|cit132","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1111\/apt.14280","article-title":"Review article: the human intestinal virome in health and disease","volume":"46","author":"Carding","year":"2017","journal-title":"Alimentary Pharmacology and Therapeutics"},{"issue":"2","key":"10.1002\/14651858.CD012774.pub3-BIB0133|cit133","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.chom.2020.01.018","article-title":"Regulatory considerations for fecal microbiota transplantation products","volume":"27","year":"2020","journal-title":"Cell Host and Microbe"},{"issue":"6","key":"10.1002\/14651858.CD012774.pub3-BIB0134|cit134","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1053\/j.gastro.2011.01.054","article-title":"The commensal microbiota and enteropathogens in the pathogenesis of inflammatory bowel diseases","volume":"140","author":"Chassaing","year":"2011","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1002\/14651858.CD012774.pub3-BIB0135|cit135","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.coi.2011.07.010","article-title":"Pathobionts of the gastrointestinal microbiota and inflammatory disease","volume":"23","author":"Chow","year":"2011","journal-title":"Current Opinion in Immunology"},{"issue":"10014","key":"10.1002\/14651858.CD012774.pub3-BIB0136|cit136","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/S0140-6736(15)00465-1","article-title":"Inherited determinants of Crohn's disease and ulcerative colitis phenotypes: a genetic association study","volume":"387","author":"Cleynen","year":"2016","journal-title":"Lancet"},{"issue":"12","key":"10.1002\/14651858.CD012774.pub3-BIB0137|cit137","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/j.crohns.2014.08.006","article-title":"Fecal microbiota transplantation as therapy for inflammatory bowel disease: a systematic review and meta-analysis","volume":"8","author":"Colman","year":"2014","journal-title":"Journal of Crohn's and Colitis"},{"issue":"42","key":"10.1002\/14651858.CD012774.pub3-BIB0138|cit138","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.15585\/mmwr.mm6542a3","article-title":"Prevalence of inflammatory bowel disease among adults aged \u226518 years \u2013 United States, 2015","volume":"65","author":"Dahlhamer","year":"2016","journal-title":"Morbidity and Mortality Weekly Report"},{"issue":"1","key":"10.1002\/14651858.CD012774.pub3-BIB0139|cit139","first-page":"29","article-title":"Mucosal healing in inflammatory bowel disease \u2013 a true paradigm of success?","volume":"8","author":"Dave","year":"2012","journal-title":"Gastroenterology and Hepatology"},{"issue":"1","key":"10.1002\/14651858.CD012774.pub3-BIB0140|cit140","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1097\/MPG.0000000000002205","article-title":"Fecal microbiota transplantation for recurrent Clostridium difficile infection and other conditions in children: a Joint Position Paper From the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition","volume":"68","author":"Davidovics","year":"2019","journal-title":"Journal of Pediatric Gastroenterology and Nutrition"},{"issue":"12","key":"10.1002\/14651858.CD012774.pub3-BIB0141|cit141","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1002\/ibd.22949","article-title":"Decreased mucosal sulfide detoxification is related to an impaired butyrate oxidation in ulcerative colitis","volume":"18","author":"De Preter","year":"2012","journal-title":"Inflammatory Bowel Diseases"},{"issue":"2","key":"10.1002\/14651858.CD012774.pub3-BIB0142|cit142","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.gie.2015.03.1974","article-title":"Assessment of mucosal healing in inflammatory bowel disease: review","volume":"82","author":"Dulai","year":"2015","journal-title":"Gastrointestinal Endoscopy"},{"issue":"7547","key":"10.1002\/14651858.CD012774.pub3-BIB0143|cit143","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1136\/bmj.332.7547.969","article-title":"Reporting attrition in randomised controlled trials","volume":"332","author":"Dumville","year":"2006","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD012774.pub3-BIB0144|cit144","unstructured":"Fecal microbiota for transplantation: safety alert \u2013 risk of serious adverse events likely due to transmission of pathogenic organisms www.fda.gov\/safety\/medical-product-safety-information\/fecal-microbiota-transplantation-safety-alert-risk-serious-adverse-events-likely-due-transmission"},{"key":"10.1002\/14651858.CD012774.pub3-BIB0145|cit145","unstructured":"Safety alert regarding use of fecal microbiota for transplantation and additional safety protections pertaining to SARS-CoV-2 and COVID-19 www.fda.gov\/vaccines-blood-biologics\/safety-availability-biologics\/safety-alert-regarding-use-fecal-microbiota-transplantation-and-additional-safety-protections"},{"key":"10.1002\/14651858.CD012774.pub3-BIB0146|cit146","unstructured":"Enforcement policy regarding investigational new drug requirements for use of fecal microbiota for transplantation to treat Clostridium difficile infection not responsive to standard therapies www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/enforcement-policy-regarding-investigational-new-drug-requirements-use-fecal-microbiota"},{"issue":"12","key":"10.1002\/14651858.CD012774.pub3-BIB0147|cit147","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1136\/jclinpath-2013-201885","article-title":"Inflammatory bowel disease biopsies: updated British Society of Gastroenterology reporting guidelines","volume":"66","author":"Feakins","year":"2013","journal-title":"Journal of Clinical Pathology"},{"issue":"10","key":"10.1002\/14651858.CD012774.pub3-BIB0148|cit148","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1111\/jgh.15598","article-title":"Fecal microbiota transplantation therapy in Crohn's disease: systematic review","volume":"36","author":"Fehily","year":"2021","journal-title":"Journal of Gastroenterology and Hepatology"},{"issue":"3","key":"10.1002\/14651858.CD012774.pub3-BIB0149|cit149","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1056\/NEJMoa2106516","article-title":"SER-109, an oral microbiome therapy for recurrent Clostridioides difficile infection","volume":"386","author":"Feuerstadt","year":"2022","journal-title":"New England Journal of Medicine"},{"issue":"8","key":"10.1002\/14651858.CD012774.pub3-BIB0150|cit150","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1038\/ismej.2017.44","article-title":"Microbial shifts and signatures of long-term remission in ulcerative colitis after faecal microbiota transplantation","volume":"11","author":"Fuentes","year":"2017","journal-title":"ISME Journal"},{"issue":"1","key":"10.1002\/14651858.CD012774.pub3-BIB0151|cit151","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S2468-1253(19)30333-4","article-title":"The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"5","author":"GBD 2017 Inflammatory Bowel Disease Collaborators","year":"2020","journal-title":"Lancet Gastroenterology and Hepatology"},{"issue":"Suppl 7","key":"10.1002\/14651858.CD012774.pub3-BIB0152|cit152","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1002\/cncr.28570","article-title":"State-of-the-science of patient navigation as a strategy for enhancing minority clinical trial accrual","volume":"120","author":"Ghebre","year":"2014","journal-title":"Cancer"},{"issue":"43","key":"10.1002\/14651858.CD012774.pub3-BIB0153|cit153","doi-asserted-by":"crossref","first-page":"7572","DOI":"10.3748\/wjg.v27.i43.7572","article-title":"Minimum sample size estimates for trials in inflammatory bowel disease: a systematic review of a support resource","volume":"27","author":"Gordon","year":"2021","journal-title":"World Journal of Gastroenterology"},{"issue":"3","key":"10.1002\/14651858.CD012774.pub3-BIB0154|cit154","doi-asserted-by":"crossref","first-page":"109","DOI":"10.4103\/2229-3485.83221","article-title":"Intention-to-treat concept: a review","volume":"2","author":"Gupta","year":"2011","journal-title":"Perspectives in Clinical Research"},{"issue":"4","key":"10.1002\/14651858.CD012774.pub3-BIB0155|cit155","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","article-title":"GRADE guidelines: 1. Introduction \u2013 GRADE evidence profiles and summary of findings tables","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD012774.pub3-BIB0156|cit156","unstructured":"Higgins JP Green S Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from training.cochrane.org\/handbook\/archive\/v5.1\/"},{"key":"10.1002\/14651858.CD012774.pub3-BIB0157|cit157","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1471-2288-5-13","article-title":"Estimating the mean and variance from the median, range, and the size of a sample","volume":"5","author":"Hozo","year":"2005","journal-title":"BMC Medical Research Methodology"},{"issue":"12","key":"10.1002\/14651858.CD012774.pub3-BIB0158|cit158","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007443.pub3","article-title":"Probiotics for maintenance of remission in ulcerative colitis","author":"Iheozor-Ejiofor","year":"2020","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD012774.pub3-BIB0159|cit159","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/ajg.2013.59","article-title":"Fecal microbiota transplantation for Clostridium difficile infection: systematic review and meta-analysis","volume":"108","author":"Kassam","year":"2013","journal-title":"American Journal of Gastroenterology"},{"issue":"3","key":"10.1002\/14651858.CD012774.pub3-BIB0160|cit160","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005573.pub3","article-title":"Probiotics for induction of remission in ulcerative colitis","author":"Kaur","year":"2020","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"7","key":"10.1002\/14651858.CD012774.pub3-BIB0161|cit161","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1038\/ajg.2014.133","article-title":"Fecal microbiota transplant for treatment of Clostridium difficile infection in immunocompromised patients","volume":"109","author":"Kelly","year":"2014","journal-title":"American Journal of Gastroenterology"},{"issue":"1","key":"10.1002\/14651858.CD012774.pub3-BIB0162|cit162","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1053\/j.gastro.2015.05.008","article-title":"Update on fecal microbiota transplantation 2015: indications, methodologies, mechanisms, and outlook","volume":"149","author":"Kelly","year":"2015","journal-title":"Gastroenterology"},{"issue":"9","key":"10.1002\/14651858.CD012774.pub3-BIB0163|cit163","doi-asserted-by":"crossref","first-page":"609","DOI":"10.7326\/M16-0271","article-title":"Effect of fecal microbiota transplantation on recurrence in multiply recurrent Clostridium difficile infection: a randomized trial","volume":"165","author":"Kelly","year":"2016","journal-title":"Annals of Internal Medicine"},{"issue":"6","key":"10.1002\/14651858.CD012774.pub3-BIB0164|cit164","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.14309\/ajg.0000000000001278","article-title":"ACG clinical guidelines: prevention, diagnosis, and treatment of Clostridioides difficile infections [published correction appears in American Journal of Gastroenterology 2022 Feb 1;117(2):358]","volume":"116","author":"Kelly","year":"2021","journal-title":"American Journal of Gastroenterology"},{"issue":"10","key":"10.1002\/14651858.CD012774.pub3-BIB0165|cit165","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1016\/j.cgh.2016.02.018","article-title":"Inflammatory bowel disease affects the outcome of fecal microbiota transplantation for recurrent Clostridium difficile infection","volume":"14","author":"Khoruts","year":"2016","journal-title":"Clinical Gastroenterology and Hepatology"},{"issue":"6","key":"10.1002\/14651858.CD012774.pub3-BIB0166|cit166","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1053\/j.gastro.2014.02.009","article-title":"The microbiome in inflammatory bowel disease: current status and the future ahead","volume":"146","author":"Kostic","year":"2014","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1002\/14651858.CD012774.pub3-BIB0167|cit167","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1097\/MPG.0b013e318292fa0d","article-title":"Safety, tolerability, and clinical response after fecal transplantation in children and young adults with ulcerative colitis","volume":"56","author":"Kunde","year":"2013","journal-title":"Journal of Pediatric Gastroenterology and Nutrition"},{"issue":"5","key":"10.1002\/14651858.CD012774.pub3-BIB0168|cit168","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/S2468-1253(21)00303-4","article-title":"Roles of the gut virome and mycobiome in faecal microbiota transplantation","volume":"7","author":"Lam","year":"2022","journal-title":"Lancet Gastroenterology and Hepatology"},{"issue":"2","key":"10.1002\/14651858.CD012774.pub3-BIB0169|cit169","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1001\/jama.2015.18098","article-title":"Frozen vs fresh fecal microbiota transplantation and clinical resolution of diarrhea in patients with recurrent Clostridium difficile infection: a randomized clinical trial","volume":"315","author":"Lee","year":"2016","journal-title":"JAMA"},{"issue":"16","key":"10.1002\/14651858.CD012774.pub3-BIB0170|cit170","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1056\/NEJMra1403772","article-title":"Clostridium difficile infection","volume":"372","author":"Leffler","year":"2015","journal-title":"New England Journal of Medicine"},{"issue":"11","key":"10.1002\/14651858.CD012774.pub3-BIB0171|cit171","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1016\/j.dld.2016.08.110","article-title":"Endoscopic peroral jejunal fecal microbiota transplantation","volume":"48","author":"Link","year":"2016","journal-title":"Digestive and Liver Disease"},{"issue":"7","key":"10.1002\/14651858.CD012774.pub3-BIB0172|cit172","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1093\/cid\/ciy149","article-title":"Clinical practice guidelines for Clostridium difficile Infection in adults and children: 2017 update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA)","volume":"66","author":"McDonald","year":"2018","journal-title":"Clinical Infectious Diseases"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD012774.pub3-BIB0173|cit173","first-page":"s51","article-title":"Report: economic implications of inflammatory bowel disease and its management","volume":"22","author":"Mehta","year":"2016","journal-title":"American Journal of Managed Care"},{"issue":"1","key":"10.1002\/14651858.CD012774.pub3-BIB0174|cit174","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1053\/j.gastro.2011.10.001","article-title":"Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review","volume":"142","author":"Molodecky","year":"2012","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1002\/14651858.CD012774.pub3-BIB0175|cit175","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1093\/cid\/cit950","article-title":"Fecal microbiota transplantation: a practical update for the infectious disease specialist","volume":"58","author":"Moore","year":"2014","journal-title":"Clinical Infectious Diseases"},{"issue":"9","key":"10.1002\/14651858.CD012774.pub3-BIB0176|cit176","doi-asserted-by":"crossref","first-page":"R79","DOI":"10.1186\/gb-2012-13-9-r79","article-title":"Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment","volume":"13","author":"Morgan","year":"2012","journal-title":"Genome Biology"},{"issue":"5","key":"10.1002\/14651858.CD012774.pub3-BIB0177|cit177","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1136\/gut.2010.224154","article-title":"Guidelines for the management of inflammatory bowel disease in adults","volume":"60","author":"Mowat","year":"2011","journal-title":"Gut"},{"issue":"4","key":"10.1002\/14651858.CD012774.pub3-BIB0178|cit178","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.jcmgh.2016.02.003","article-title":"Functional characterization of inflammatory bowel disease-associated gut dysbiosis in gnotobiotic mice","volume":"2","author":"Nagao-Kitamoto","year":"2016","journal-title":"Cellular and Molecular Gastroenterology and Hepatology"},{"issue":"6","key":"10.1002\/14651858.CD012774.pub3-BIB0179|cit179","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1007\/s40615-021-01161-x","article-title":"Communication challenges faced by Spanish-speaking caregivers of children with medical complexity: a qualitative study","volume":"9","author":"Nageswaran","year":"2022","journal-title":"Journal of Racial and Ethnic Health Disparities"},{"issue":"5","key":"10.1002\/14651858.CD012774.pub3-BIB0180|cit180","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001176.pub4","article-title":"Treatment and prevention of pouchitis after ileal pouch-anal anastomosis for chronic ulcerative colitis","author":"Nguyen","year":"2019","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD012774.pub3-BIB0181|cit181","doi-asserted-by":"crossref","first-page":"159","DOI":"10.18865\/ed.30.S1.159","article-title":"Why African Americans say \"no\": a study of pharmacogenomic research participation","volume":"30","author":"Nooruddin","year":"2020","journal-title":"Ethnicity and Disease"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD012774.pub3-BIB0182|cit182","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1093\/ofid\/ofw194.48","article-title":"Donor efficacy in fecal microbiota transplantation for recurrent Clostridium difficile: evidence from a 1,999-patient cohort","volume":"3","author":"Osman","year":"2016","journal-title":"Open Forum Infectious Diseases"},{"issue":"9","key":"10.1002\/14651858.CD012774.pub3-BIB0183|cit183","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.tim.2013.07.003","article-title":"Fecal microbiota transplantation and donor standardization","volume":"21","author":"Owens","year":"2013","journal-title":"Trends in Microbiology"},{"issue":"10","key":"10.1002\/14651858.CD012774.pub3-BIB0184|cit184","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1093\/ecco-jcc\/jjx063","article-title":"Faecal microbiota transplantation for inflammatory bowel disease: a systematic review and meta-analysis","volume":"11","author":"Paramsothy","year":"2017","journal-title":"Journal of Crohn's and Colitis"},{"issue":"7","key":"10.1002\/14651858.CD012774.pub3-BIB0185|cit185","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1111\/cmi.12308","article-title":"Defining dysbiosis and its influence on host immunity and disease","volume":"16","author":"Petersen","year":"2014","journal-title":"Cellular Microbiology"},{"issue":"5","key":"10.1002\/14651858.CD012774.pub3-BIB0186|cit186","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.crohns.2011.06.009","article-title":"Results from the 2nd Scientific Workshop of the ECCO. I: impact of mucosal healing on the course of inflammatory bowel disease","volume":"5","author":"Peyrin-Biroulet","year":"2011","journal-title":"Journal of Crohn's and Colitis"},{"issue":"12","key":"10.1002\/14651858.CD012774.pub3-BIB0187|cit187","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.3748\/wjg.v23.i12.2124","article-title":"Diet and microbiota in inflammatory bowel disease: the gut in disharmony","volume":"23","author":"Rapozo","year":"2017","journal-title":"World Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD012774.pub3-BIB0188|cit188","unstructured":"Review Manager Web (RevMan Web) The Cochrane Collaboration 2023"},{"issue":"6150","key":"10.1002\/14651858.CD012774.pub3-BIB0189|cit189","doi-asserted-by":"crossref","first-page":"1241214","DOI":"10.1126\/science.1241214","article-title":"Gut microbiota from twins discordant for obesity modulate metabolism in mice","volume":"341","author":"Ridaura","year":"2013","journal-title":"Science"},{"issue":"9","key":"10.1002\/14651858.CD012774.pub3-BIB0190|cit190","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1111\/apt.16309","article-title":"Randomised clinical trial: a 12-strain bacterial mixture versus faecal microbiota transplantation versus vancomycin for recurrent Clostridioides difficile infections","volume":"53","author":"Rode","year":"2021","journal-title":"Alimentary Pharmacology and Therapeutics"},{"issue":"6","key":"10.1002\/14651858.CD012774.pub3-BIB0191|cit191","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1053\/j.gastro.2021.01.010","article-title":"Long-term safety of fecal microbiota transplantation for recurrent Clostridioides difficile infection","volume":"160","author":"Saha","year":"2021","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1002\/14651858.CD012774.pub3-BIB0192|cit192","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/imj.13003","article-title":"Characterisation and therapeutic manipulation of the gut microbiome in inflammatory bowel disease","volume":"46","author":"Schulberg","year":"2016","journal-title":"Internal Medicine Journal"},{"issue":"6","key":"10.1002\/14651858.CD012774.pub3-BIB0193|cit193","doi-asserted-by":"crossref","first-page":"e0157259","DOI":"10.1371\/journal.pone.0157259","article-title":"Fecal microbiota transplantation for ulcerative colitis: a systematic review and meta-analysis","volume":"11","author":"Shi","year":"2016","journal-title":"PLOS One"},{"issue":"2","key":"10.1002\/14651858.CD012774.pub3-BIB0194|cit194","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1093\/cid\/ciu278","article-title":"Tempered enthusiasm for fecal transplant","volume":"59","author":"Solari","year":"2014","journal-title":"Clinical Infectious Diseases"},{"issue":"23","key":"10.1002\/14651858.CD012774.pub3-BIB0195|cit195","doi-asserted-by":"crossref","first-page":"e3765","DOI":"10.1097\/MD.0000000000003765","article-title":"Fecal microbiota transplantation as a novel therapy for ulcerative colitis: a systematic review and meta-analysis","volume":"95","author":"Sun","year":"2016","journal-title":"Medicine (Baltimore)"},{"issue":"5","key":"10.1002\/14651858.CD012774.pub3-BIB0196|cit196","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1056\/NEJMoa1205037","article-title":"Duodenal infusion of donor feces for recurrent Clostridium difficile","volume":"368","author":"Nood","year":"2013","journal-title":"New England Journal of Medicine"},{"issue":"4","key":"10.1002\/14651858.CD012774.pub3-BIB0197|cit197","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1177\/1756283X16644242","article-title":"The intestinal microbiome, barrier function, and immune system in inflammatory bowel disease: a tripartite pathophysiological circuit with implications for new therapeutic directions","volume":"9","author":"Vindigni","year":"2016","journal-title":"Therapeutic Advances in Gastroenterology"},{"issue":"44","key":"10.1002\/14651858.CD012774.pub3-BIB0198|cit198","doi-asserted-by":"crossref","first-page":"16745","DOI":"10.3748\/wjg.v20.i44.16745","article-title":"Temporal trends in inflammatory bowel disease publications over a 19-years period","volume":"20","author":"Weintraub","year":"2014","journal-title":"World Journal of Gastroenterology"},{"issue":"4","key":"10.1002\/14651858.CD012774.pub3-BIB0199|cit199","doi-asserted-by":"crossref","first-page":"56","DOI":"10.3390\/jof3040056","article-title":"The human mucosal mycobiome and fungal community interactions","volume":"3","author":"Witherden","year":"2017","journal-title":"Journal of Fungi (Basel)"},{"issue":"11","key":"10.1002\/14651858.CD012774.pub3-BIB0200|cit200","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1093\/cid\/ciu135","article-title":"Fecal microbiota transplant for relapsing Clostridium difficile infection using a frozen inoculum from unrelated donors: a randomized, open-label, controlled pilot study","volume":"58","author":"Youngster","year":"2014","journal-title":"Clinical Infectious Diseases"},{"issue":"10","key":"10.1002\/14651858.CD012774.pub3-BIB0201|cit201","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1111\/1751-2980.12933","article-title":"Efficacy and safety of fecal microbiota transplantation for treating patients with ulcerative colitis: a systematic review and meta-analysis","volume":"21","author":"Zhao","year":"2020","journal-title":"Journal of Digestive Diseases"},{"issue":"8","key":"10.1002\/14651858.CD012774.pub3-BIB0202|cit202","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012774","article-title":"Fecal transplantation for treatment of inflammatory bowel disease","author":"Imdad","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"11","key":"10.1002\/14651858.CD012774.pub3-BIB0203|cit203","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012774.pub2","article-title":"Fecal transplantation for treatment of inflammatory bowel disease","author":"Imdad","year":"2018","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T16:03:07Z","timestamp":1760457787000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD012774.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane Gut Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2023,4,25]]},"references-count":203,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,4]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd012774.pub3","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,25]]}}}